Maurizio Fava Selected Research

Fluoxetine (Prozac)

6/2012	Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
7/2011	Response rates to fluoxetine in subjects who initially show no improvement.
4/2011	A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
3/2011	Examining the role of race and ethnicity in relapse rates of major depressive disorder.
7/2010	Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.
3/2010	Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
2/2010	Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
1/2009	The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
10/2008	Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
9/2008	A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Fava Research Topics

Disease

284	Major Depressive Disorder (Major Depressive Disorders) 10/2022 - 03/2002
37	Treatment-Resistant Depressive Disorder 03/2022 - 03/2002
22	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2020 - 01/2002
20	Fatigue 10/2020 - 01/2003
12	Weight Gain 01/2022 - 01/2002
11	Headache (Headaches) 01/2022 - 08/2003
11	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 06/2003
11	Nausea 01/2022 - 01/2005
11	Mood Disorders (Mood Disorder) 01/2020 - 07/2002
11	Medically Unexplained Symptoms 03/2016 - 04/2002
9	Anxiety Disorders (Anxiety Disorder) 04/2011 - 09/2002
8	Schizophrenia (Dementia Praecox) 01/2022 - 08/2009
8	Depressive Disorder (Melancholia) 01/2021 - 10/2002
7	Sleepiness 01/2022 - 01/2005
7	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2008
7	Cognitive Dysfunction 01/2020 - 01/2004
7	Psychomotor Agitation (Akathisia) 11/2018 - 04/2008
6	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2022 - 04/2006
6	Inflammation (Inflammations) 01/2021 - 08/2014
6	Pain (Aches) 12/2015 - 01/2003
5	Mental Disorders (Mental Disorder) 01/2017 - 08/2008
4	Dizziness (Lightheadedness) 01/2022 - 05/2005
4	Neoplasms (Cancer) 01/2021 - 06/2004
4	Personality Disorders (Personality Disorder) 01/2021 - 09/2002
4	Obesity 05/2020 - 11/2013
4	Anhedonia 01/2019 - 01/2012
4	Constipation 11/2018 - 08/2003
4	Neurobehavioral Manifestations 01/2018 - 11/2006
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2017 - 05/2002
4	Alcoholism (Alcohol Abuse) 02/2016 - 01/2009
4	Tobacco Use Disorder (Nicotine Dependence) 07/2015 - 11/2010
4	Erectile Dysfunction 02/2013 - 09/2002
4	Hypercholesterolemia 03/2004 - 07/2002
3	Dementia (Dementias) 01/2022 - 01/2009
3	Panic Disorder (Panic Attack) 01/2021 - 11/2019
3	Overweight 05/2020 - 03/2003
3	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 01/2012
3	Stroke (Strokes) 01/2018 - 06/2004
3	Mania (Manias) 04/2017 - 11/2003
3	Body Weight (Weight, Body) 08/2016 - 03/2005
3	Disorders of Excessive Somnolence (Hypersomnia) 08/2007 - 01/2004

Drug/Important Bio-Agent (IBA)

157	Antidepressive Agents (Antidepressants)IBA 10/2022 - 04/2002
51	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2020 - 01/2002
51	Fluoxetine (Prozac)FDA LinkGeneric 06/2012 - 01/2002
21	Citalopram FDA LinkGeneric 08/2014 - 10/2005
19	Escitalopram FDA Link 01/2020 - 10/2005
17	Bupropion (Wellbutrin)FDA LinkGeneric 01/2022 - 09/2002
16	Pharmaceutical PreparationsIBA 10/2020 - 07/2002
14	Aripiprazole (Abilify)FDA Link 01/2017 - 10/2005
14	Duloxetine Hydrochloride (Cymbalta)FDA Link 03/2009 - 04/2004
13	Ketamine FDA LinkGeneric 03/2022 - 01/2016
10	Sertraline (Zoloft)FDA LinkGeneric 10/2022 - 04/2002
10	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 02/2004
9	EmbarcIBA 10/2022 - 09/2015
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2004
8	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 11/2013 - 12/2004
8	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 03/2002
7	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 01/2003
7	Nortriptyline (Aventyl)FDA LinkGeneric 08/2014 - 01/2003
7	HomocysteineIBA 06/2012 - 08/2004
7	CholesterolIBA 08/2009 - 07/2002
6	ziprasidone (Geodon)FDA Link 01/2018 - 02/2004
6	Serotonin (5 Hydroxytryptamine)IBA 06/2009 - 01/2003
6	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2005 - 03/2003
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2006
5	Biological ProductsIBA 01/2021 - 09/2006
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 01/2016
5	Opioid Analgesics (Opioids)IBA 01/2020 - 05/2015
5	5-methyltetrahydrofolateIBA 05/2016 - 06/2012
5	Mirtazapine (Rexer)FDA LinkGeneric 11/2013 - 01/2002
4	pimavanserinIBA 01/2022 - 01/2019
4	Modafinil (Provigil)FDA Link 01/2022 - 01/2005
4	Glutamic Acid (Glutamate)FDA Link 12/2017 - 06/2009
4	Buspirone (Buspar)FDA LinkGeneric 09/2015 - 03/2006
4	Eszopiclone (Lunesta)FDA Link 01/2012 - 06/2006
4	DNA (Deoxyribonucleic Acid)IBA 04/2010 - 06/2007
4	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2009 - 08/2005
3	ViloxazineIBA 11/2022 - 01/2021
3	Hormones (Hormone)IBA 01/2022 - 08/2007
3	LipidsIBA 01/2021 - 06/2014
3	Zolpidem (Ambien)FDA LinkGeneric 01/2020 - 06/2009
3	Buprenorphine (Subutex)FDA LinkGeneric 01/2020 - 05/2016
3	MelatoninIBA 01/2020 - 12/2012
3	Methionine (L-Methionine)FDA Link 01/2020 - 08/2010
3	3-carboxamido-4-hydroxynaltrexoneIBA 01/2020 - 05/2016
3	Riluzole FDA LinkGeneric 11/2019 - 09/2013
3	3,4-methylenedioxyethamphetamine (MDEA)IBA 04/2017 - 01/2006
3	brexpiprazoleIBA 01/2017 - 12/2016
3	Nicotine FDA Link 09/2014 - 10/2011
3	Sildenafil Citrate (Viagra)FDA Link 02/2013 - 09/2002
3	Illicit Drugs (Recreational Drugs)IBA 01/2013 - 03/2003
3	LithiumIBA 09/2006 - 02/2003
3	Paroxetine (Paxil)FDA LinkGeneric 10/2005 - 01/2002
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2022
2	N-Methylaspartate (NMDA)IBA 01/2022 - 08/2016

Therapy/Procedure

47	Therapeutics 01/2022 - 09/2002
15	Drug Therapy (Chemotherapy) 01/2020 - 06/2003
4	Secondary Prevention 01/2018 - 06/2003
3	Aftercare (After-Treatment) 01/2022 - 01/2010
3	Tai Ji (Tai Chi Chuan) 07/2018 - 10/2012